Z-VAD-FMK

Z-VAD-FMK

Contact us: [email protected]

Z-VAD-FMK

A1902-10 10 mg
EUR 408
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-25 25 mg
EUR 616.8
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-5 5 mg
EUR 268.8
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-5.1 10 mM (in 1mL DMSO)
EUR 268.8
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

HY-16658B 10mg
EUR 786

Z-VAD(OMe)-FMK

HY-16658 10mg
EUR 472.8

Z-VAD-FMK, cell permeable

GL1523-1MG 1 mg
EUR 330

Z-VAD-FMK, cell permeable

GL1523-5MG 5 mg
EUR 950.4

Caspase-Family Inhibitor Z-VAD-FMK

1010-100
EUR 235.2

Caspase-Family Inhibitor Z-VAD-FMK

1010-20C
EUR 235.2

SRB-VAD-FMK [Sulforhodamine B-VAD-FMK]

13472 25 Tests
EUR 158.4

Z-VAD-FMK (Pan-specific caspase inhibitor)

SIH-557-1MG 1 mg
EUR 231.6
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml).

Biotin-VAD-FMK

1123-20C
EUR 392.4

FAM-VAD-FMK

13470 25 Tests
EUR 158.4

TF4-VAD-FMK

13471 25 Tests
EUR 158.4

FITC-VAD-FMK

9497-100
EUR 430.8

Biotin-VAD-FMK

HY-100894 1mg
EUR 1216.8

mFluor™ 450-VAD-FMK

13475 25 Tests
EUR 158.4

mFluor™ 510-VAD-FMK

13476 25 Tests
EUR 158.4

Z-YVAD-FMK

1141-1
EUR 405.6

Z-YVAD-FMK

1141-5
EUR 966

Z-VDVAD-FMK

1142-1
EUR 366

Z-VDVAD-FMK

1142-5
EUR 966

Z-DEVD-FMK

1143-1
EUR 379.2

Z-DEVD-FMK

1143-5
EUR 966

Z-LEVD-FMK

1144-1
EUR 379.2

Z-LEVD-FMK

1144-5
EUR 966

Z-VEID-FMK

1146-1
EUR 366

Z-VEID-FMK

1146-5
EUR 966

Z-IETD-FMK

1148-1
EUR 392.4

Z-IETD-FMK

1148-5
EUR 940.8

Z-LEHD-FMK

1149-1
EUR 379.2

Z-LEHD-FMK

1149-5
EUR 920.4

Z-ATAD-FMK

1152-1
EUR 418.8

Z-ATAD-FMK

1152-5
EUR 1096.8

Z-FA-FMK

1986-1
EUR 176.4

Z-FA-FMK

1986-5
EUR 444

Z-YVAD-FMK

A8955-1 1 mg
EUR 282
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK

A8955-5 5 mg
EUR 616.8
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK

A8955-5.1 10 mM (in 1mL DMSO)
EUR 1326
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-FA-FMK

A8170-1 1 mg
EUR 142.8
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-10 10 mg
EUR 560.4
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-25 25 mg
EUR 616.8
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-5 5 mg
EUR 338.4
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-5.1 10 mM (in 1mL DMSO)
EUR 408
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-S Evaluation Sample
EUR 97.2
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-DEVD-FMK

A1920-1 1 mg
EUR 135.6
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-10 10 mg
EUR 408
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-25 25 mg
EUR 616.8
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-5 5 mg
EUR 268.8
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-5.1 10 mM (in 1mL DMSO)
EUR 351.6
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-S Evaluation Sample
EUR 97.2
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DQMD-FMK

A1921-1 1 mg
EUR 135.6
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-10 10 mg
EUR 408
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-25 25 mg
EUR 616.8
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-5 5 mg
EUR 268.8
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-S Evaluation Sample
EUR 97.2
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-VDVAD-FMK

A1922-1 1 mg
EUR 212.4
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-10 10 mg
EUR 756
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-25 25 mg
EUR 1173.6
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-5 5 mg
EUR 477.6
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-S Evaluation Sample
EUR 97.2
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VEID-FMK

A1923-1 1 mg
EUR 212.4
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-10 10 mg
EUR 756
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-25 25 mg
EUR 1173.6
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-5 5 mg
EUR 477.6
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-S Evaluation Sample
EUR 97.2
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-WEHD-FMK

A1924-1 1 mg
EUR 135.6
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-10 10 mg
EUR 408
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-25 25 mg
EUR 616.8
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-5 5 mg
EUR 268.8
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-AEVD-FMK

B1162-1
EUR 405.6

Z-VRPR-FMK

B1238-1000
EUR 1096.8

Z-VRPR-FMK

B1238-250
EUR 405.6

Z-IETD-FMK

B3232-1 1 mg
EUR 393.6
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK

B3232-5 5 mg
EUR 547.2
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK

B3232-5.1 10 mM (in 1mL DMSO)
EUR 1201.2
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-LEHD-FMK

B3233-1 1 mg
EUR 420
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-LEHD-FMK

B3233-5 5 mg
EUR 1054.8
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-VRPR-FMK

GL3755-1MG 1 mg
EUR 702

Z-VRPR-FMK

GL3755-500UG 500 ug
EUR 426

Z-IETD-FMK

HY-101297 5mg
EUR 555.6

Z-DEVD-FMK

HY-12466 10mg
EUR 471.6

Calpain Inhibitor, Z-LLY-FMK

B1506-1000
EUR 405.6

Calpain Inhibitor, Z-LLY-FMK

B1506-250
EUR 261.6

Caspase-5 Inhibitor Z-WEHD-FMK

1100-100
EUR 235.2

Caspase-5 Inhibitor Z-WEHD-FMK

1100-20C
EUR 235.2

Caspase-4 Inhibitor Z-LEVD-FMK

1108-100
EUR 222

Caspase-4 Inhibitor Z-LEVD-FMK

1108-20C
EUR 222

EZSolution? Calpain Inhibitor, Z-LLY-FMK

1125-20C
EUR 222

EMAP-II Inhibitor Z-ASTD-FMK

1127-20C
EUR 314.4

Caspase-3 Inhibitor Z-DEVD-FMK

1009-100
EUR 248.4

Caspase-3 Inhibitor Z-DEVD-FMK

1009-20C
EUR 248.4

Caspase-6 Inhibitor Z-VEID-FMK

1011-100
EUR 222

Caspase-6 Inhibitor Z-VEID-FMK

1011-20C
EUR 222

Caspase-1 Inhibitor Z-YVAD-FMK

1012-100
EUR 235.2

Caspase-1 Inhibitor Z-YVAD-FMK

1012-20C
EUR 235.2

Caspase-8 Inhibitor Z-IETD-FMK

1064-100
EUR 235.2

Caspase-8 Inhibitor Z-IETD-FMK

1064-20C
EUR 235.2

Caspase-2 Inhibitor Z-VDVAD-FMK

1073-100
EUR 222

Caspase-2 Inhibitor Z-VDVAD-FMK

1073-20C
EUR 222

Caspase-9 Inhibitor Z-LEHD-FMK

1074-100
EUR 248.4

Caspase-9 Inhibitor Z-LEHD-FMK

1074-20C
EUR 248.4

Caspase-12 Inhibitor Z-ATAD-FMK

1079-100
EUR 261.6

Caspase-12 Inhibitor Z-ATAD-FMK

1079-20C
EUR 261.6

Caspase-3 inhibitor, Z-DQMD-FMK

2782-1
EUR 170.4

Caspase-3 inhibitor, Z-DQMD-FMK

2782-5
EUR 496.8

Caspase-8 Inhibitor Z-IETD-FMK

B4096-.02 20 µl (10 mM)
EUR 234
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-8 Inhibitor Z-IETD-FMK

B4096-.1 100 µl (2 mM)
EUR 234
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-9 Inhibitor Z-LEHD-FMK

B4573-.02 20 µl (10 mM)
EUR 234
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-9 Inhibitor Z-LEHD-FMK

B4573-.1 100 µl (2 mM)
EUR 234
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Cathepsin B&L Inhibitor Z-Phe-Phe-FMK

1126-20C
EUR 274.8

FMK

A3420-10 10 mg
EUR 447.6
Description: FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway.

FMK

HY-52101A 10mM/1mL
EUR 403.2

FMK-MEA

HY-52101C 5mg
EUR 817.2

FMK 9a

HY-100522 10mM/1mL
EUR 560.4

BOC-Asp(OMe)-FMK [Boc-D(OMe)-FMK]

5310 1 mg
EUR 158.4

BOC-Asp(OMe)-FMK [Boc-D(OMe)-FMK]

5311 10 mg
EUR 576

Biotin-IETD-FMK

1121-20C
EUR 444

FMK Negative Control

1122-100
EUR 210

FMK Negative Control

1122-20C
EUR 210

Biotin-DEVD-FMK

1124-20C
EUR 444

Boc-D-FMK

1160-1
EUR 261.6

Boc-D-FMK

1160-5
EUR 639.6

FAM-LETD-FMK

13416 100 ug
EUR 315.6

Biotin-VDVAD-FMK

1032-20C
EUR 444

Biotinyl-ASTD-FMK

1985-1000
EUR 723.6

Biotinyl-ASTD-FMK

1985-500
EUR 418.8

Boc-D-FMK

A1904-1 1 mg
EUR 129.6
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-10 10 mg
EUR 373.2
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-25 25 mg
EUR 756
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-5 5 mg
EUR 268.8
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-5.1 10 mM (in 1mL DMSO)
EUR 261.6
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

FITC-VDVAD-FMK

9498-100
EUR 430.8

FITC-DEVD-FMK

9499-100
EUR 430.8

FITC-IETD-FMK

9533-100
EUR 430.8

FITC-LEHD-FMK

9534-100
EUR 430.8

BOC-D-FMK

HY-13229 1mg
EUR 142.8

FITC-C6-DEVD-FMK

13406 1 mg
EUR 576

FITC-C6-LEHD-FMK

13407 1 mg
EUR 576

FITC-C6-DEVD-FMK

13408 100 ug
EUR 262.8

FITC-C6-LEHD-FMK

13409 100 ug
EUR 262.8

Z-VAD-FMK